The Blue Jays have agreed to a two-year minor league deal with right-hander Nic Enright, according to a report from ESPN’s Alden Gonzalez.
Enright, 28, has had a difficult career to this point despite solid results. A 20th-round pick by Cleveland back in 2019, the righty made his way up the organizational ladder to reach Triple-A with excellent results in 2022. That seemingly put him on the radar for a call-up to the majors, but was diagnosed with Hodgkin Lymphoma in December of that year. The diagnosis came shortly after Enright was selected by the Marlins in the Rule 5 draft and severely limited him throughout the 2023 campaign, although he did eventually begin a rehab assignment while undergoing treatment. He struggled before being returned to the Guardians, but by 2024 was back to posting excellent numbers in the minors.
That earned Enright the opportunity to make his MLB debut this year, and he made the most of the opportunity with a sterling 2.03 ERA and a 23.7% strikeout rate in 31 innings of work. Enright had the look of a quality bullpen piece when on the mound, but his health derailed things once again when the righty underwent Tommy John surgery in October. The timing of that injury will cost Enright the entire 2026 season, which led the Guardians to non-tender him last month despite his status as a pre-arbitration player. That sent Enright into minor league free agency for the first time in his career, and he’s now managed to catch on with the reigning AL champions.
The deal between Toronto and Enright is for both the 2026 and ’27 seasons. While minor league deals are typically for just one year, two-year deals are somewhat common for talented players who are rehabbing from significant surgery. They serve as a way for the acquiring club to take control of the player’s rehab process with the assurance that they’ll be the organization with the first crack at reaping the benefits once the player returns to health. From the player’s perspective, the two-year guarantee offers some security that otherwise would not be afforded to them, saving them from having to go back into minor league free agency coming off a season lost to rehab.
While Enright won’t have an impact on the Blue Jays in 2026, it would hardly be a surprise to see him join the Toronto bullpen at some point in 2027 given his previous results and obvious talent when healthy. The Blue Jays’ pitching staff figures to look very different in 2027, as Shane Bieber and Kevin Gausman will depart the rotation for free agency after the 2026 campaign while Eric Lauer and Yimi Garcia figure to leave a hole in the bullpen when they hit the open market. It’s hard to know exactly how open the competition for Toronto’s 2027 pitching staff will be more than a year in advance, but it’s certainly plausible that those impending departures could help create an opportunity for Enright to join players like Jeff Hoffman, Tyler Rogers, and Louis Varland in the team’s relief corps once he’s healthy.